ihl-42x
Generic: dronabinol and acetazolamide
ihl-42x: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Incannex Healthcare Inc. (IXHL) | Phase 2/Phase 3 |
Clinical Trials (1)
A Phase II/III, Randomised, Double-Blind Clinical Trial to Determine the Safety and Efficacy of IHL-42X in Subjects With Obstructive Sleep Apnoea Who Are Intolerant, Non-Compliant, or Naïve to Positive Airway Pressure
Frequently asked questions
Who is developing ihl-42x?
ihl-42x is being developed by Incannex Healthcare Inc..
How many clinical trials involve ihl-42x?
BioSniper tracks 1 clinical trial involving ihl-42x.
Get deeper analysis on ihl-42x
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis